Tactile Systems Technology, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Tactile Systems Technology, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 15.9 times. Higher than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 13.4 times by its yearly operating cash. Higher than 87% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$185Over the last 3 years, every $100 of reported profit came with $185 of operating cash.
Higher than 71% of Healthcare companies in United States.
Self-Funding Ratio
15.9×Over the last 3 years its own operating cash covered its investment spending (capex) 15.9 times.
Higher than 96% of Healthcare companies in United States.
Cash Locked Ratio
$15For every $100 of sales, $15 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $27 tied up three years earlier.
Less money tied up than 69% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$45Sales grew 34% in 3 years; of every extra $100 of sales, $45 became extra profit.
Higher than 67% of Healthcare companies in United States.
Asset Productivity Ratio
+34% / +7%In 3 years sales changed by +34% while total assets changed by +7%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
13.4×Debt due within a year is covered 13.4 times by its yearly operating cash.
Higher than 87% of Healthcare companies in United States.
Cash Cushion Ratio
+16%Cash, after subtracting all debt, equals 16% of its market value (net cash).
Higher than 58% of Healthcare companies in United States.
Tangible Assets Ratio
74%Of every $100 the company owns, $74 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 58% of Healthcare companies in United States.
Tangible Net Worth Ratio
68%Of every $100 of net worth, $68 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 55% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Tactile Systems Technology, Inc. owes $0.20 for every $1 it owns. Net profit rose 13% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
21.8Investors pay $21.8 for every $1 of Tactile Systems Technology, Inc.'s yearly profit, lower than 60% of Healthcare companies in United States.
P/B ratio
2.38The share price is 2.38 times Tactile Systems Technology, Inc.'s book value per share, lower than 53% of Healthcare companies in United States.
Market cap
$533 MThe total market value of all of Tactile Systems Technology, Inc.'s shares at today's price (share price × number of shares), larger than 56% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$224 MWhat Tactile Systems Technology, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$9.88Net worth divided by the number of shares. The share price of $23.54 is 2.4 times this, which is the P/B above.
Return on equity (ROE)
11.9%Tactile Systems Technology, Inc. earned 11.9% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
Owes vs Owns
0.20×Tactile Systems Technology, Inc. owes $0.20 for every $1 it owns (low), lower than 72% of Healthcare companies in United States.
Dividend yield
NoneTactile Systems Technology, Inc. does not currently pay a dividend.
Revenue growth
+12%Revenue rose 12% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit growth
+13%Net profit rose 13% in the year to Dec 2025.
Profit margin
5.8%Tactile Systems Technology, Inc. keeps $6 of every $100 of revenue as net profit.
Cash quality
2.2×Cash from Tactile Systems Technology, Inc.'s business was 2.2× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
28.2×Tactile Systems Technology, Inc.'s operating profit covered its interest costs 28.2 times in the year to Dec 2025.
Cash vs debt
Net cashTactile Systems Technology, Inc. held $83 M more cash than debt (net cash) at Dec 2025.
Questions
What is Tactile Systems Technology, Inc.'s P/E ratio?
Investors pay $21.8 for every $1 of Tactile Systems Technology, Inc.'s yearly profit, lower than 60% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Tactile Systems Technology, Inc.: $533 M ÷ $224 M (30 Jun 2026) = 2.4.
What is Tactile Systems Technology, Inc.'s return on equity?
Tactile Systems Technology, Inc. earned 11.9% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
How much does Tactile Systems Technology, Inc. owe compared with what it owns?
Tactile Systems Technology, Inc. owes $0.20 for every $1 it owns (low), lower than 72% of Healthcare companies in United States.
Does Tactile Systems Technology, Inc. pay a dividend?
No. Tactile Systems Technology, Inc. does not currently pay a dividend.
Is Tactile Systems Technology, Inc.'s revenue growing?
Revenue rose 12% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.